IFNA1 and cancer: One of the most recognized pro-tumoral activities of IFNs is the induction or overexpression of a subset of ISGs in distinct cancers, identified as an IFN-related DNA damage-resistant signature (IRDS), that confers tumor cell resistance to therapy (94, 95).